Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature
2014 ◽
Vol 94
(6)
◽
pp. 554-557
◽
Keyword(s):
2017 ◽
Vol 6
(4)
◽
pp. 539-542
◽
Keyword(s):